HopeStage
Back to all studies
UnknownNCT06636357

Nitrous oxide for acute suicidal thoughts: a randomized study

About this titleRead the official source — NCT06636357
Medication studyAges 18–65SwitzerlandSuicide prevention
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ZurichSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 13, 2025
Recruitment status
Unknown
Enrollment listed in the registry
85
Sponsor
University of Zurich
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Switzerland
Age range
From 18 Years to 65 Years
Official registry ID
NCT06636357
Official title
Show the full official title

Nitrous Oxide in the Treatment of Acute Suicidal Ideation

Recruitment & locations

Status unknown

Zurich

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Zurich, a university.

Does this study involve medication?

Yes. The study involves medication, including 50% N2O plus 50% O2 and Oxygen (O2).

Who can participate?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies